基本信息
-
髓鞘少突胶质细胞糖蛋白
-
149635-73-4
-
髓鞘少突胶质细胞糖蛋白;H-MEVGWYRSPFSRVVHLYRNGK-OH;MET-GLU-VAL-GLY-TRP-TYR-ARG-PRO-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS;MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS: MEVGWYRSPFSRVVHLYRNGK;髓鞘少突胶质细胞糖蛋白 149635-73-4
-
C118H177N35O29S
-
2581.95
-
L-Lysine,L-methionyl-L-a-glutamyl-L-valylglycyl-L-tryptophyl-L-tyrosyl-L-arginyl-L-seryl-L-prolyl-L-phenylalanyl-L-seryl-L-arginyl-L-valyl-L-valyl-L-histidyl-L-leucyl-L-tyrosyl-L-arginyl-L-asparaginylglycyl-
-
-
1.48±0.1 g/cm3(Predicted)
-
10:PN: JP2008100970 SEQID: 10 unclaimed protein; 10: PN: WO2005044982 PAGE: 43unclaimed sequence; 10: PN: WO2009063998 SEQID: 11 unclaimed protein; 11: PN:US20090280135 SEQID: 42 unclaimed sequence; 11: PN: WO2007096396 SEQID: 11unclaimed sequence; 131: PN: US20060204508 SEQID: 99 unclaimed sequence; 137:PN: WO2008037504 SEQID: 191 unclaimed sequence; 13: PN: WO0172325 PAGE: 17unclaimed sequence; 14: PN: CN101020063 PAGE: 29 unclaimed sequence; 15: PN:WO2008096359 SEQID: 15 unclaimed protein; 16: PN: WO2007061805 SEQID: 16unclaimed sequence; 17: PN: WO2008146272 SEQID: 19 unclaimed protein; 18: PN:WO2007096398 SEQID: 11 unclaimed sequence; 190: PN: WO2009109643 SEQID: 191unclaimed sequence; 1: PN: US20050032210 SEQID: 1 unclaimed sequence; 1: PN:US20090209516 PAGE: 12 unclaimed sequence; 1: PN: WO0044408 SEQID: 1 claimedprotein; 1: PN: WO0230447 PAGE: 13 unclaimed sequence; 1: PN: WO0230448 PAGE:15 unclaimed sequence; 1: PN: WO2006056783 PAGE: 28 unclaimed sequence; 1: PN:WO2006066088
-
-
-
-
详细信息
杭州专肽生物（www.allpeptide.com）一直致力于、专注于修饰多肽的合成及研发，目前已经在很多方面取得了突破，并获得定制多肽行业的认可。 各类修饰让多肽的结构丰富起来，可以在多肽的N端、C端、活性侧链基团（羧基、氨基、羟基、酚羟基、巯基等）进行改造或形成各类环肽。同时多肽修饰让多肽的运用更加广泛起来，几乎所有的生物研究领域都有涉及到多肽，包括比较热门的肿瘤领域、生物材料领域，核磁共振领域等。
各类糖肽
各类荧光标记肽（Fam、FITC、TAMRRA、CY等）
含有DOTA、NOTA、DTPA等放射性螯合物前体多肽
众多羧基化合物和氨基化合物修饰的肽段
引入叠氮、炔基、烯基结构的肽段及点击化学运用
小分子、大分子PEG修饰
环肽（如酰胺、二硫键、硫酯、硫醚键、脲基成环）
引入叠氮、炔基、烯基结构的肽段及点击化学运用
同位素标记肽
环二肽
KLH和BSA蛋白载体多肽
R8S9订书肽
Dansyl和EDANS双标记肽
磷酸化肽磺酸化肽
甲基化肽
MAPs多聚抗原肽
醛肽
CMK、AMC、pNA
